Atlas Trials

Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human Subjects

Clinical trial NCT01299285 · COMPLETED

Trial details

NCT number
NCT01299285
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2011-02-01
Primary completion
2011-03-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.